Cargando…

Evaluation of the role of local therapy in patients with cN1M0 prostate cancer: A population-based study from the SEER database

OBJECTIVE: To investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa). METHODS: Patients diagnosed with cN1M0 PCa were extracted from the surveillance, epidemiology, and end results (SEER) database. Kaplan-Meier (KM) curve was used to compare the survival outcomes betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Feng, Xu, Wenbo, Li, Lu, Li, Xiao, Xu, Zicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760928/
https://www.ncbi.nlm.nih.gov/pubmed/36544700
http://dx.doi.org/10.3389/fonc.2022.1050317
_version_ 1784852592160931840
author Qi, Feng
Xu, Wenbo
Li, Lu
Li, Xiao
Xu, Zicheng
author_facet Qi, Feng
Xu, Wenbo
Li, Lu
Li, Xiao
Xu, Zicheng
author_sort Qi, Feng
collection PubMed
description OBJECTIVE: To investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa). METHODS: Patients diagnosed with cN1M0 PCa were extracted from the surveillance, epidemiology, and end results (SEER) database. Kaplan-Meier (KM) curve was used to compare the survival outcomes between patients treated with and without LT. Further, among patients receiving LT, KM analysis was also applied to investigate the survival differences in patients with radical prostatectomy (RP) and radiation therapy (RT). Propensity score matching (PSM) analysis was performed to balance the basic characteristics of patients in each group and make it comparable when exploring the survival impact of different treatment types. Finally, uni- and multivariable Cox proportional-hazards models were utilized to identify independent prognostic factors associated with overall survival (OS) and cancer-specific survival (CSS) in this population. RESULTS: Patients treated with LT had significantly better OS (P<0.0001) and CSS (P<0.0001) than those without LT, as well as in most subgroups, except for non-White patients, or those with ISUP grade group 1 or T3 stage. Notably, patients receiving RP also had significantly better OS (P=0.00012) and CSS (P=0.0045) than those treated with RT alone, especially in those aged ≥75 years old, prostate-specific antigen (PSA) 10-20 ng/mL, ISUP grade 1-3 or non-white patients. Finally, clinical T stage, ISUP grade group and the administration of LT were identified to be independent prognostic factors for OS and CSS among cN1M0 PCa patients. CONCLUSION: The cN1M0 PCa patients treated with LT were associated with significantly better survival. Among patients receiving LT, the combination of RP and PLND could lead to a better prognosis compared to RT alone in most subgroups. An individualized treatment strategy is warranted to be developed after weighing the benefits and risks of treatment.
format Online
Article
Text
id pubmed-9760928
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97609282022-12-20 Evaluation of the role of local therapy in patients with cN1M0 prostate cancer: A population-based study from the SEER database Qi, Feng Xu, Wenbo Li, Lu Li, Xiao Xu, Zicheng Front Oncol Oncology OBJECTIVE: To investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa). METHODS: Patients diagnosed with cN1M0 PCa were extracted from the surveillance, epidemiology, and end results (SEER) database. Kaplan-Meier (KM) curve was used to compare the survival outcomes between patients treated with and without LT. Further, among patients receiving LT, KM analysis was also applied to investigate the survival differences in patients with radical prostatectomy (RP) and radiation therapy (RT). Propensity score matching (PSM) analysis was performed to balance the basic characteristics of patients in each group and make it comparable when exploring the survival impact of different treatment types. Finally, uni- and multivariable Cox proportional-hazards models were utilized to identify independent prognostic factors associated with overall survival (OS) and cancer-specific survival (CSS) in this population. RESULTS: Patients treated with LT had significantly better OS (P<0.0001) and CSS (P<0.0001) than those without LT, as well as in most subgroups, except for non-White patients, or those with ISUP grade group 1 or T3 stage. Notably, patients receiving RP also had significantly better OS (P=0.00012) and CSS (P=0.0045) than those treated with RT alone, especially in those aged ≥75 years old, prostate-specific antigen (PSA) 10-20 ng/mL, ISUP grade 1-3 or non-white patients. Finally, clinical T stage, ISUP grade group and the administration of LT were identified to be independent prognostic factors for OS and CSS among cN1M0 PCa patients. CONCLUSION: The cN1M0 PCa patients treated with LT were associated with significantly better survival. Among patients receiving LT, the combination of RP and PLND could lead to a better prognosis compared to RT alone in most subgroups. An individualized treatment strategy is warranted to be developed after weighing the benefits and risks of treatment. Frontiers Media S.A. 2022-12-05 /pmc/articles/PMC9760928/ /pubmed/36544700 http://dx.doi.org/10.3389/fonc.2022.1050317 Text en Copyright © 2022 Qi, Xu, Li, Li and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Qi, Feng
Xu, Wenbo
Li, Lu
Li, Xiao
Xu, Zicheng
Evaluation of the role of local therapy in patients with cN1M0 prostate cancer: A population-based study from the SEER database
title Evaluation of the role of local therapy in patients with cN1M0 prostate cancer: A population-based study from the SEER database
title_full Evaluation of the role of local therapy in patients with cN1M0 prostate cancer: A population-based study from the SEER database
title_fullStr Evaluation of the role of local therapy in patients with cN1M0 prostate cancer: A population-based study from the SEER database
title_full_unstemmed Evaluation of the role of local therapy in patients with cN1M0 prostate cancer: A population-based study from the SEER database
title_short Evaluation of the role of local therapy in patients with cN1M0 prostate cancer: A population-based study from the SEER database
title_sort evaluation of the role of local therapy in patients with cn1m0 prostate cancer: a population-based study from the seer database
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760928/
https://www.ncbi.nlm.nih.gov/pubmed/36544700
http://dx.doi.org/10.3389/fonc.2022.1050317
work_keys_str_mv AT qifeng evaluationoftheroleoflocaltherapyinpatientswithcn1m0prostatecancerapopulationbasedstudyfromtheseerdatabase
AT xuwenbo evaluationoftheroleoflocaltherapyinpatientswithcn1m0prostatecancerapopulationbasedstudyfromtheseerdatabase
AT lilu evaluationoftheroleoflocaltherapyinpatientswithcn1m0prostatecancerapopulationbasedstudyfromtheseerdatabase
AT lixiao evaluationoftheroleoflocaltherapyinpatientswithcn1m0prostatecancerapopulationbasedstudyfromtheseerdatabase
AT xuzicheng evaluationoftheroleoflocaltherapyinpatientswithcn1m0prostatecancerapopulationbasedstudyfromtheseerdatabase